Investigation of cellular and molecular mechanisms of caffeic acid phenethyl ester loaded nanoparticle systems in breast cancer cell lines

• Published in: Process biochemistry (1991) Vol. 134; pp. 32 - 43
• Main Authors: Poyraz, Fatma Sayan, Colpan, Reyhan Dilsu, Derman, Serap, Mansuroglu, Banu, Erdemir, Aysegul
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 01-11-2023
• Subjects: Anti-tumor activity; Breast cancer; CAPE; Polymeric nanoparticle; NP; PLGA; Anti-tumor activity; Polymeric nanoparticle; Breast cancer; CAPE; CAPE-NPs
• ISSN: 1359-5113; 1873-3298
• DOI: 10.1016/j.procbio.2023.09.016

Breast cancer is associated with high morbidity and mortality in women since conventional treatment methods are limited due to toxicity problems and inadequate targeting of cancer cells. The aim of this study is to develop caffeic acid phenethyl ester (CAPE) loaded polymeric nanoparticles to provide treatment for breast cancer and investigate their anti-tumor activity on MCF-7 and MDA-MB-231 breast cancer cells. CAPE was encapsulated into poly lactic-co-glycolic acid (PLGA) polymer using single-emulsion (o/w) solvent evaporation method and characterization of CAPE loaded PLGA nanoparticles (CAPE-NPs) were performed by particle size, zeta potential, polydispersity index, in vitro release profile, and surface morphology. CAPE-NPs were tested for cytotoxicity, anti-migration, anti-proliferation and apoptotic activities on breast cancer cells. The mean nanoparticle size was found as 196,1 ± 8982 nm and polydispersity index (PDI) was 0186 ± 0069. The results of the in vitro cell culture studies indicated that treatment of breast cancer cells with CAPE and CAPE-NPs inhibited cell viability and proliferation. IC50 values for 48 h were determined as 28.35 μg/ml,19.57 μg/ml for CAPE and CAPE-NP, respectively. Additionally, CAPE-NPs induced intrinsic pathway of apoptosis in MCF-7 and MDA-MB-231 cell lines. Overall, CAPE-NPs showed more efficient anti-tumour activity on breast cancer cells by small size and enhanced bioavability.
[Display omitted]
•The aim of this study is to develop CAPE-NPs to provide treatment for breast cancer.•CAPE loaded PLGA nanoparticles were produced (CAPE-NPs).•CAPE-NPs anti-tumour activity was evaluated on breast cancer cell lines.•CAPE-NPs exhibited higher cytotoxicity than CAPE due to their small size and controlled release.•CAPE-NPs demonstrated a decrease in cell proliferation and induced the intrinsic pathway of apoptosis.